Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP780316.RAT97R74snO9-_OOETtG7yybHSJWyd_qlz7CijEExNzoo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP780316.RAT97R74snO9-_OOETtG7yybHSJWyd_qlz7CijEExNzoo130_assertion type Assertion NP780316.RAT97R74snO9-_OOETtG7yybHSJWyd_qlz7CijEExNzoo130_head.
- NP780316.RAT97R74snO9-_OOETtG7yybHSJWyd_qlz7CijEExNzoo130_assertion description "[Carriers of the XRCC1_1196_AA genotype had a reduced risk for recurrence/death (odds ratio adjusted 0.19; 95% confidence interval: 0.06-0.61), which was observed in survival analyses of all patients (P=0.003) and patients treated with chemotherapy but not radiotherapy (P=0.006).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP780316.RAT97R74snO9-_OOETtG7yybHSJWyd_qlz7CijEExNzoo130_provenance.
- NP780316.RAT97R74snO9-_OOETtG7yybHSJWyd_qlz7CijEExNzoo130_assertion evidence source_evidence_literature NP780316.RAT97R74snO9-_OOETtG7yybHSJWyd_qlz7CijEExNzoo130_provenance.
- NP780316.RAT97R74snO9-_OOETtG7yybHSJWyd_qlz7CijEExNzoo130_assertion SIO_000772 17558308 NP780316.RAT97R74snO9-_OOETtG7yybHSJWyd_qlz7CijEExNzoo130_provenance.
- NP780316.RAT97R74snO9-_OOETtG7yybHSJWyd_qlz7CijEExNzoo130_assertion wasDerivedFrom befree-20150227 NP780316.RAT97R74snO9-_OOETtG7yybHSJWyd_qlz7CijEExNzoo130_provenance.
- NP780316.RAT97R74snO9-_OOETtG7yybHSJWyd_qlz7CijEExNzoo130_assertion wasGeneratedBy ECO_0000203 NP780316.RAT97R74snO9-_OOETtG7yybHSJWyd_qlz7CijEExNzoo130_provenance.